Form 4: Hinge Health Director Acquires Class A Stock

Tyler Sloat, a Director at Hinge Health, Inc., acquired 68 shares of Class A Common Stock through the settlement of vested RSUs on April 5, 2026.

Summary

• Tyler Sloat, a Director at Hinge Health, Inc., acquired 68 shares of Class A Common Stock.
• The acquisition occurred on April 5, 2026, with a transaction price of $42.399 per share.
• These shares were issued upon the settlement of fully vested restricted stock units (RSUs).
• The RSUs were granted on April 5, 2026, as an alternative to quarterly cash retainers, as per the company's Non-Employee Director Compensation Program.
• Following this transaction, Sloat beneficially owns 9,964 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction related to director compensation rather than a significant strategic or financial event.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The settlement of RSUs indicates the fulfillment of compensation obligations to a director.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of Class A Common Stock by a director, are common disclosures for publicly traded companies and can provide insights into management's perception of the company's value. The use of RSUs for director compensation is a standard practice in the tech and healthcare sectors.

Stakeholder Impact

• Shareholders: The acquisition by a director may be interpreted as a positive signal of confidence in the company's performance and future prospects.

Key Dates

Keywords

Hinge Health, HNGE, Form 4, Insider Trading, Class A Common Stock, Restricted Stock Units, Director Compensation